Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,670.00
Bid: 1,670.50
Ask: 1,671.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.03%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,670.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets pull back from five-month high as banks fall

Wed, 23rd Oct 2013 11:15

Concerns over the Chinese economy and a weak performance by banking stocks halted a nine-day winning streak for UK markets on Wednesday, as investors chose to take profits following a strong run.The FTSE 100 snapped a nine-day winning streak this morning, pulling back from Tuesday's finish of 6,695.66, the index's highest closing high since May 28th when it closed at 6,762.01.Stocks have surged over the past week as investors celebrated the end to the US government shutdown and the short-term deal to raise the debt ceiling. Meanwhile, hopes over a continuation of Federal Reserve monetary stimulus were sparked yesterday after a disappointing September jobs report.Weighing on markets this morning was a sharp sell-off across Asian indices overnight on the back of concerns over the Chinese banking sector following a report that said that debt write-offs at the country's biggest lenders tripled in the first half. Investors were also focusing on the People's Bank of China's decision on Wednesday to refrain from adding liquidity to the market through new reverse repurchase operations, which led to a sharp increase in the country's benchmark money market rate. In other news, the minutes of the latest Bank of England meeting were released this morning and showed that the Monetary Policy Committee was unanimous in its decision to keep policy unchanged as recent economic data pointed to a "robust recovery in activity".Banks, ex-div stocks provide a dragBanks all over Europe were out of favour after the European Central Bank said it would start to review the balance sheets of 130 institutions across the continent. RBS, Barclays, Lloyds, HSBC and Standard Chartered were all registering losses in London.A number of stocks were also trading in the red after going ex-dividend, including Smiths Group, BAE System, Rolls-Royce, John Menzies, Senior, William Hill, Rank Group, Barratt Developments and JD Wetherspoon.Banknote printer and ID services firm De La Rue was a big mover with shares sinking after the company warned that it would miss its full-year profit target by £10m owing to "challenging trading conditions".Drugs group GlaxoSmithKline was also weighing on the market ahead of the release of its third-quarter results due out later on amid concerns over the impact of a corruption probe in China on sales.Chip designer ARM Holdings fell for the second straight day as investors gave a cool reaction to its third-quarter results. JPMorgan Cazenove said this morning that it sees "no reason to be building positions at this time and would take profits in the short term."Sports Direct edged higher after saying that sales in the nine weeks to September 29th were up 15.1% despite some tough comparatives with last year. Fellow retailer Home Retail also rose after a 53% jump in first-half profits owing to sales growth at its Argos and Homebase chains.Costa and Premier Inn owner Whitbread was lower after Deutsche Bank downgraded the stock to 'hold', saying that it's time to "consolidate and take stock" after a great year.Meanwhile, telecoms firm Vodafone was in demand as speculation continues to ramp up about a possible bid from US counterpart AT&T. Credit Suisse has raised its target for the UK-listed stock, saying it sees a 50% chance of a bid.FTSE 100 - RisersRSA Insurance Group (RSA) 127.00p +2.50%Persimmon (PSN) 1,244.00p +1.39%International Consolidated Airlines Group SA (CDI) (IAG) 363.80p +1.34%Travis Perkins (TPK) 1,804.00p +1.23%United Utilities Group (UU.) 713.50p +1.21%Resolution Ltd. (RSL) 351.40p +1.15%Legal & General Group (LGEN) 212.40p +1.14%Capita (CPI) 985.50p +1.13%Shire Plc (SHP) 2,521.00p +1.12%Weir Group (WEIR) 2,361.00p +1.11%FTSE 100 - FallersSmiths Group (SMIN) 1,394.00p -4.19%Anglo American (AAL) 1,510.00p -2.96%Antofagasta (ANTO) 878.00p -2.88%Royal Bank of Scotland Group (RBS) 353.20p -2.43%Rio Tinto (RIO) 3,187.00p -2.28%CRH (CRH) 1,513.00p -2.07%ARM Holdings (ARM) 983.50p -2.04%BHP Billiton (BLT) 1,914.50p -1.85%Barclays (BARC) 267.70p -1.80%GlaxoSmithKline (GSK) 1,575.00p -1.62%FTSE 250 - RisersLaird (LRD) 239.90p +6.29%Pace (PIC) 303.80p +4.76%Home Retail Group (HOME) 191.60p +3.96%African Barrick Gold (ABG) 172.60p +3.35%Kenmare Resources (KMR) 22.48p +3.26%IP Group (IPO) 145.90p +3.04%Alent (ALNT) 363.00p +2.25%Chemring Group (CHG) 219.80p +2.19%Telecom Plus (TEP) 1,514.00p +2.16%BH Global Ltd. USD Shares (BHGU) 11.63 +2.02%FTSE 250 - FallersDe La Rue (DLAR) 889.50p -9.33%International Personal Finance (IPF) 622.00p -6.96%Premier Oil (PMO) 323.10p -4.97%Telecity Group (TCY) 786.00p -4.96%Centamin (DI) (CEY) 49.65p -4.24%Evraz (EVR) 129.50p -3.50%Kazakhmys (KAZ) 253.40p -3.28%AZ Electronic Materials SA (DI) (AZEM) 288.80p -2.43%Soco International (SIA) 405.20p -1.89%Hansteen Holdings (HSTN) 106.00p -1.85%BC
More News
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.